CALGARY, Alberta, July 08, 2025 (GLOBE NEWSWIRE) -- In a significant move that connects biotechnology, preventative health, and global wellness trends, Canadian biotechnology company BioAro has announced the launch of its first...

CALGARY, Alberta, July 08, 2025 (GLOBE NEWSWIRE) -- In a significant
Step that combines biotechnology, preventive health and global wellness trends
The Canadian biotechnology company BioAro has developed the
Launch of its first nutraceutical from its new range of nutritional supplements
announced: Longevity+(TM), a patent-pending, scientifically
formulated capsule, which through the synergistic integration of several molecules
to support healthy aging. After the approvals in the
United Arab Emirates (UAE), BioAro is now
ready for expansion to North America, Europe, the UK and beyond
beyond.
The launch of Longevity+(TM) comes at a crucial time as the
Global longevity and healthy aging market expected to reach 44
billion USD, driven by growing demand for
advanced nutraceuticals that go beyond basic nutritional supplementation
BioAro’s entry into this area is anything but
It combines cutting-edge research, clinical findings and multi-
Omics intelligence – hallmark of its biotechnological origins – to a
Product based on science, not hype.
A groundbreaking, comprehensive protocol for longevity
What sets Longevity+(TM) apart is not only its formula, but also its
Philosophy: Simplicity meets synergy. Each daily dose (two capsules)
contains an effective blend of nicotinamide mononucleotide (NMN),
Resveratrol, coenzyme Q10, curcumin, vitamin D and vitamin B12 - molecules that
individually the cellular energy, the health of the mitochondria, the
Support inflammation modulation and cognitive clarity. Previous
However, scientific studies indicate that they are in a
precisely coordinated ratio can achieve synergistic effects that enhance their
individual benefits and possibly an integrated path to
Offer an extension of the health span.
?We didn't want to be just another supplement company
", explains Dr. Anmol Kapoor, founder of BioAro. "Our formula is the
The result of years of precise health research in the fields of genomics,
Metabolomics and personalized medicine. We have Longevity+ from
systems biology perspective and focused on how
Molecules interact - not just how they function individually."
From the laboratory to everyday life: The global ambitions of a Canadian
biotechnology company
The range of dietary supplements is based on the many years of experience of
BioAro in the areas of precision diagnostics and AI-supported multi-omics and
is the company’s first health product for end consumers.
is the result of years of complex research and has been translated into a simple,
daily protocol implemented.
With regulatory approval and marketing authorization in the United
United Arab Emirates, one of the world’s most advanced markets for
Innovations in health and wellness, BioAro is currently
Distribution partnerships in North America, Europe, Great Britain, India and
Southeast Asia. The company also plans to integrate Longevity+ into its clinical
longevity programs, including personalized
Health assessments and digital wellness tracking to provide a comprehensive
ecosystem for people who proactively manage their aging and vitality
want to control.
The content is crucial
* NMN (nicotinamide mononucleotide): A powerful NAD+ precursor that
is essential for mitochondrial health and cell repair.
* Resveratrol: A polyphenol known to activate sirtuins
and mimic the benefits of calorie restriction.
* Coenzyme Q10: Essential for heart and energy metabolism,
especially in older people.
* Curcumin: A powerful anti-inflammatory and antioxidant agent from
Turmeric.
* Vitamin D and B12: Essential for immune regulation, neurocognitive
Health and metabolism.
This formulation represents a shift towards systemic thinking
in dietary supplements where the aim is not to supply the body with
isolated nutrients, but rather the harmony at the molecular level
to restore.
Patent pending, performance-oriented
Longevity+(TM) is currently undergoing a major transformation due to its novel combination and
Delivery mechanism is under patent review. BioAro uses its
proprietary research results to optimize nutrient absorption and
Bioavailability. Clinical pilot studies are underway in Canada and the
United Arab Emirates in the planning phase, with a focus on
tracking biomarkers to validate results in real populations
validate.
Redefining the future of aging
With its entry into the longevity supplements market, BioAro does not plan
not just the sale of dietary supplements, but a new narrative around
to develop the topic of aging, in prevention and performance
meet and scientifically sound strategies fragmented
Replace wellness advice.
?We envision a future in which people proactively manage their aging
shape, supported by data, precision and powerful science",
adds Dr. Kapoor. "Longevity+ is just the beginning."
About BioAro
BioAro Inc. is a Canadian biotechnology and
Precision healthcare company focused on multi-omics, AI-enabled
Diagnostics and preventive medicine. With offices in
Canada, the USA, the GCC states, South America, the EU and Great Britain
BioAro is a pioneer in the integration of genomics, wearable technology and
personalized therapeutics into everyday healthcare solutions.
Exclusive offer!
As part of our commitment to personalized well-being, BioAro offers
all users who have the app Biongevity Playstore
(https://play.google.com/store/apps/details?id=com.biongevity.com&pcampaignid=we
b_share) and Apple Store (https://apps.apple.com/ca/app/biongevity/id6670455479)
or visit our website at www.biongevity.com
(http://www.biongevity.com/) to receive an exclusive discount on our
high-quality nutritional supplements for a long life. Start now
Start your journey to better health today!
For media inquiries, distribution partnerships or product samples, please contact
please contact:
Media contact:
Mohini
Email: [email protected],
Phone: +1-403-250-2221
For more information please visit: www.BioAro.com
(http://www.bioaro.com/) | www.biongevity.com (http://www.biongevity.com/)
--------------------------------------------------------------------------------
Longevity+(TM) is a trademark of BioAro Inc. Patent pending. These statements
have not been reviewed by the supervisory authorities of all jurisdictions. This
Product is not intended to diagnose, treat, cure or prevent
diseases.
Photos related to this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/b696ab44-9f1f-4fa0-89dc-
e221bc2010d2
https://www.globenewswire.com/NewsRoom/AttachmentNg/ca4969a1-f8b7-404a-a505-
674b3eb975a3
https://www.globenewswire.com/NewsRoom/AttachmentNg/86acd16a-ca50-48c9-b51c-
237d91e36d51
Â